Skip to Content
Merck
CN
All Photos(1)

Documents

Safety Information

1.04002

SAFC

Formaldehyde solution

37%, EMPROVE® EVOLVE

Pharma Manufacturing

Sign Into View Organizational & Contract Pricing
All Photos(1)
Synonym(s):
Formaline solution, Methanal solution, Methylaldehyde solution
UNSPSC Code:
12352114

description

stabilized with about 10% methanol Ph Eur,BP,USP

Quality Level

400

product line

EMPROVE® EVOLVE

form

liquid

autoignition temp.

300 °C (Formaldehyde)

expl. lim.

7-73 % (v/v) Formaldehyde()

concentration

36.5-38% (iodometric)
37%

pH

2.8-4.0 (20 °C in H2O)

bp

93-96 °C/1013 hPa

mp

<-15 °C

transition temp

flash point 62 °C (Formaldehyde)

density

1.09 g/cm3 at 20 °C

application(s)

histology
pharma/biopharma processes
pharmaceutical

storage temp.

15-25°C

Related Categories

General description

We offer a range of high quality critical raw materials plus the documentation and expertise to help our customers meet stringent regulatory requirements. Our SAFC® portfolio of high-quality products withstands strict quality control procedures.

Application

Formaldehyde can be used for virus inactivation in vaccine production.

Linkage

Replaces: 1.04002.2507; 1.04002.9187

Legal Information

Emprove is a registered trademark of Merck KGaA, Darmstadt, Germany
SAFC is a registered trademark of Merck KGaA, Darmstadt, Germany

Signal Word

Danger

Hazard Classifications

Acute Tox. 2 Inhalation - Acute Tox. 3 Dermal - Acute Tox. 3 Oral - Carc. 1B - Eye Dam. 1 - Muta. 2 - Skin Corr. 1B - Skin Sens. 1 - STOT SE 1 - STOT SE 3

Target Organs

Eyes,Central nervous system, Respiratory system

WGK

WGK 3

Flash Point(F)

143.6 °F

Flash Point(C)

62 °C

Regulatory Information

危险化学品

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

João M Fernandes Neto et al.
Nature communications, 11(1), 3157-3157 (2020-06-24)
Resistance to targeted cancer drugs is thought to result from selective pressure exerted by a high drug dose. Partial inhibition of multiple components in the same oncogenic signalling pathway may add up to complete pathway inhibition, while decreasing the selective

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service